TG Therapeutics, Inc. (TGTX) financial statements (2020 and earlier)

Company profile

Business Address 2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK, NY 10014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1406985451027945
Cash and cash equivalents113425725555640
Short-term investments282728202223 
Other undisclosed cash, cash equivalents, and short-term investments(0)   2505
Receivables 00000 
Other current assets1000000
Other undisclosed current assets81086(16)6(3)
Total current assets:149799351878542
Noncurrent Assets
Operating lease, right-of-use asset9
Property, plant and equipment0000000
Long-term investments and receivables    25 5
Long-term investments    25 5
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Regulated entity, other noncurrent assets2      
Restricted cash and investments 11111 
Other noncurrent assets   0000
Other undisclosed noncurrent assets1222   
Total noncurrent assets:145442726
TOTAL ASSETS:1638497551138748
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3036261594 
Other undisclosed accounts payable and accrued liabilities3036261594 
Debt2000001
Deferred compensation liability4221111
Deferred revenue and credits00000
Other liabilities49      
Other undisclosed current liabilities 0    5
Total current liabilities:843928171156
Noncurrent Liabilities
Long-term debt and lease obligation39     0
Long-term debt, excluding current maturities29     0
Operating lease, liability10
Liabilities, other than long-term debt12022122
Deferred revenue and credits22122
Deferred revenue1
Deferred rent credit 1
Other liabilities 18     
Other undisclosed noncurrent liabilities 1     
Total noncurrent liabilities:402122122
Total liabilities:1246030191278
Stockholders' equity
Stockholders' equity attributable to parent392467361028079
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital74055342227226017580
Accumulated deficit(701)(528)(355)(236)(158)(95) 
Other undisclosed stockholders' equity    00(39)
Total stockholders' equity:392467361028040
TOTAL LIABILITIES AND EQUITY:1638497551138748

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net00000
Amortization of lease incentives(0) 
Other income10   
Gross profit:0000000
Operating expenses(169)(175)(119)(79)(63)(56)(23)
Operating loss:(169)(174)(119)(79)(63)(56)(23)
Nonoperating income (expense)(4)1010(0)2
Investment income, nonoperating00(0)(0)(1)(0)0
Interest and debt expense(5)   (1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes5   111
Net loss available to common stockholders, diluted:(173)(173)(118)(78)(63)(56)(20)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(173)(173)(118)(78)(63)(56)(20)
Comprehensive loss, net of tax, attributable to parent:(173)(173)(118)(78)(63)(56)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: